Cow's Milk Protein Allergy Clinical Trial
Official title:
A Retrospective and Comparative Study on the Journey of Children With Cow´s Milk Protein Allergy in Mexico: Current Practice in Allergy Management in Mexican Children Aged ≤24 Months
To gain insights on the application, use and effectiveness of Frisolac Gold Intensive HA and Frisolac Gold PEP AC with reference to improvement of CMPA symptoms and to determine the methodology used by Mexican Health Care Professionals (HCPs) in the clinical practice (i.e. diagnosis and dietary management) of CMPA in Mexican children (≤24 months) diagnosed with or suspected of CMPA.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT06130085 -
Partially Hydrolyzed Formula in Cow's Milk Protein Allergy After 6 Months of Elimination
|
N/A | |
| Completed |
NCT03769051 -
Study on The Oral Immune Tolerance of CMPA Infants Using Amino Acid Formula
|
||
| Completed |
NCT02953223 -
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
|
||
| Completed |
NCT03085134 -
Clinical Safety & Efficacy of a New Infant Formula With Specific Medical Purpose Containing Human Milk Oligosaccharides
|
N/A | |
| Recruiting |
NCT06288503 -
Hydrolysed Rice Formula Study
|
N/A | |
| Completed |
NCT06273371 -
Tolerance and Growth Outcomes in Children Diagnosed With Cow's Milk Protein Allergy and Prescribed an Extensively Hydrolyzed Casein Formula (Damira 2000©) in Spain
|